Subscribe To Our Free Newsletter |
Glenmark to sell 75% in life sciences arm to Nirma
Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore.